Literature DB >> 10678934

High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria.

C Aucan1, Y Traoré, F Tall, B Nacro, T Traoré-Leroux, F Fumoux, P Rihet.   

Abstract

There is accumulating evidence for a role of immunoglobulin G (IgG) in protection against malarial infection and disease. Only IgG1 and IgG3 are considered cytophilic and protective against P. falciparum, whereas IgG2 and IgG4 were thought to be neither and even to block protective mechanisms. However, no clear pattern of association between isotypes and protection has so far emerged. We analyzed the isotypic distribution of the IgG response to conserved epitopes and P. falciparum blood-stage extract in 283 malaria-exposed individuals whose occurrence of infection and malaria attack had been monitored for about 1 year. Logistic regression analyses showed that, at the end of the season of transmission, high levels of IgG2 to RESA and to MSP2 epitopes were associated with low risk of infection. Indeed, IgG2 is able to bind FcgammaRIIA in individuals possessing the H131 allele, and we showed that 70% of the study subjects had this allele. Also, high specific IgG4 levels were associated with an enhanced risk of infection and with a high risk of malaria attack. Moreover, specific IgG2 and IgG3 levels, as well as the IgG2/IgG4 and IgG3/IgG4 ratios, increased with the age of subjects, in parallel with the protection against infection and disease. IgG4 likely competes with cytophilic antibodies for antigen recognition and may therefore block cytotoxicity mediated by antibody-activated effector cells. In conclusion, these results favor a protective role of IgG3 and IgG2, which may activate effector cells through FcgammaRIIA, and provide evidence for a blocking role of IgG4 in malarial infection and disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678934      PMCID: PMC97275          DOI: 10.1128/IAI.68.3.1252-1258.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum.

Authors:  W E Collins; R F Anders; M Pappaioanou; G H Campbell; G V Brown; D J Kemp; R L Coppel; J C Skinner; P M Andrysiak; J M Favaloro
Journal:  Nature       Date:  1986 Sep 18-24       Impact factor: 49.962

2.  Rapid detection of the Fc gamma RIIA-H/R 131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED).

Authors:  X M Jiang; G Arepally; M Poncz; S E McKenzie
Journal:  J Immunol Methods       Date:  1996-11-29       Impact factor: 2.303

3.  In vitro and in vivo studies on protective and inhibitory antibodies against Plasmodium falciparum in the Saimiri monkey.

Authors:  T Fandeur; P Dubois; J Gysin; J P Dedet; L P da Silva
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

4.  Human malaria: segregation analysis of blood infection levels in a suburban area and a rural area in Burkina Faso.

Authors:  P Rihet; L Abel; Y Traoré; T Traoré-Leroux; C Aucan; F Fumoux
Journal:  Genet Epidemiol       Date:  1998       Impact factor: 2.135

5.  A theoretical framework for the immunoepidemiology of Plasmodium falciparum malaria.

Authors:  S Gupta; K P Day
Journal:  Parasite Immunol       Date:  1994-07       Impact factor: 2.280

6.  On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2.

Authors:  P W Parren; P A Warmerdam; L C Boeije; J Arts; N A Westerdaal; A Vlug; P J Capel; L A Aarden; J G van de Winkel
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

7.  A versatile synthetic peptide-based ELISA for identifying antibody epitopes.

Authors:  J M Ball; N L Henry; R C Montelaro; M J Newman
Journal:  J Immunol Methods       Date:  1994-05-02       Impact factor: 2.303

Review 8.  Interleukin-4 and interleukin-13: their similarities and discrepancies.

Authors:  P Chomarat; J Banchereau
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

9.  Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity.

Authors:  E M Riley; S J Allen; J G Wheeler; M J Blackman; S Bennett; B Takacs; H J Schönfeld; A A Holder; B M Greenwood
Journal:  Parasite Immunol       Date:  1992-05       Impact factor: 2.280

10.  Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages.

Authors:  H Bouharoun-Tayoun; C Oeuvray; F Lunel; P Druilhe
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  67 in total

1.  Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.

Authors:  Carlota Dobaño; Diana Quelhas; Llorenç Quintó; Laura Puyol; Elisa Serra-Casas; Alfredo Mayor; Tacilta Nhampossa; Eusebio Macete; Pedro Aide; Inacio Mandomando; Sergi Sanz; Sanjeev K Puniya; Bijender Singh; Puneet Gupta; Arindam Bhattacharya; Virander S Chauhan; John J Aponte; Chetan E Chitnis; Pedro L Alonso; Clara Menéndez
Journal:  Clin Vaccine Immunol       Date:  2011-12-14

2.  Immunoglobulin G isotype responses to variant surface antigens of Plasmodium falciparum in healthy Gabonese adults and children during and after successive malaria attacks.

Authors:  Gerardo Cabrera; Clarisse Yone; Anne E Tebo; Jan van Aaken; Bertrand Lell; Peter G Kremsner; Adrian J F Luty
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

3.  Factors associated with immunoglobulin G subclass polarization in naturally acquired antibodies to Plasmodium falciparum merozoite surface proteins: a cross-sectional survey in Brazilian Amazonia.

Authors:  Kézia K G Scopel; Cor J F Fontes; Marcelo U Ferreira; Erika M Braga
Journal:  Clin Vaccine Immunol       Date:  2006-07

4.  A malaria serological map indicating the intersection between parasite antigenic diversity and host antibody repertoires.

Authors:  H A Giha; A A Nasr; N C Iriemenam; K Berzins; M Troye-Blomberg; D E Arnot; G Elghazali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-29       Impact factor: 3.267

5.  Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria.

Authors:  J Eric Tongren; Christopher J Drakeley; Suzanna L R McDonald; Hugh G Reyburn; Alphaxard Manjurano; Watoky M M Nkya; Martha M Lemnge; Channe D Gowda; Jim E Todd; Patrick H Corran; Eleanor M Riley
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

6.  Immunogenicity and antigenicity of Plasmodium vivax merozoite surface protein 10.

Authors:  Yang Cheng; Bo Wang; Jetsumon Sattabongkot; Chae Seung Lim; Takafumi Tsuboi; Eun-Taek Han
Journal:  Parasitol Res       Date:  2014-04-25       Impact factor: 2.289

7.  Poly(I:C) adjuvant strongly enhances parasite-inhibitory antibodies and Th1 response against Plasmodium falciparum merozoite surface protein-1 (42-kDa fragment) in BALB/c mice.

Authors:  Akram Abouie Mehrizi; Niloufar Rezvani; Sedigheh Zakeri; Atefeh Gholami; Laleh Babaeekhou
Journal:  Med Microbiol Immunol       Date:  2018-02-03       Impact factor: 3.402

8.  When is a malaria immune complex not an immune complex?

Authors:  R J Pleass
Journal:  Parasite Immunol       Date:  2009-02       Impact factor: 2.280

9.  Impact of child malnutrition on the specific anti-Plasmodium falciparum antibody response.

Authors:  Florie Fillol; Jean Biram Sarr; Denis Boulanger; Badara Cisse; Cheikh Sokhna; Gilles Riveau; Kirsten Bork Simondon; Franck Remoué
Journal:  Malar J       Date:  2009-06-02       Impact factor: 2.979

10.  FcgammaRIIa (CD32) polymorphism and anti-malarial IgG subclass pattern among Fulani and sympatric ethnic groups living in eastern Sudan.

Authors:  Amre Nasr; Nnaemeka C Iriemenam; Hayder A Giha; Halima A Balogun; Robin F Anders; Marita Troye-Blomberg; Gehad ElGhazali; Klavs Berzins
Journal:  Malar J       Date:  2009-03-13       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.